We have examined the expression and secretion of endogenous parathyroid hormone-like peptide (PLP) 
Introduction
We have examined the expression and secretion of endogenous parathyroid hormone-like peptide (PLP) in primary cultures of normal human keratinocytes. In response to growth factors and fetal bovine serum, PLP mRNA expression and immunoreactive PLP release into conditioned medium was rapidly increased (within hours) whereas these effects were inhibited by 1,25-dihydroxyvitamin D3 11,25(OH)2D31. These early responses were not influenced by raising the medium calcium concentration from 0.15 to 1.0 mM. In contrast, increasing the medium calcium concentration to 1.0 mM, addition of 1,25(OH)2D3, or a combination of both, resulted in a delayed augmentation (after several days) in PLP production which was associated with an increase in cellular differentiation as assessed by production of high molecular weight keratin. To investigate whether these factors were acting at the level of transcription of the PLP gene, a series of vectors were prepared by fusing segments of the 5' flanking region of the rat PLP gene to a growth hormone reporter gene. Transient transfection of these constructs into cultured keratinocytes and measurement of immunoreactive growth hormone in the medium showed that a region stimulated by growth factors is located in a 1.9-kb fragment of the 5' flanking region and that a PLP gene promoter region < 1.2 kb and > 0.3 kb upstream of the cap site contains cis-acting elements which respond positively to serum, and negatively to 1,25(OH)2D3. These combined studies demonstrate that, in normal human keratinocytes, growth factors may acutely stimulate PLP mRNA levels and PLP release, whereas 1,25(OH)2D3 inhibits these responses. At least part of these effects are at the level of gene transcription. Additionally, PLP synthesis and release are enhanced under conditions in which keratinocyte differentiation is induced. (J. Clin. Invest. 1991. 87:884-893.) Key words: calcium * epidermal growth factorkeratinocyte differentiation * transient transfection Messenger RNAs and the gene encoding parathyroid hormone (PTH)-like peptide (PLP),' which was initially isolated from human tumors associated with hypercalcemia (1-3), have now been cloned and characterized in the human (4-9) and rat (10) (11) (12) . PLP mimics many of the biological actions of PTH (13) , but is also likely to have its own functions which are separate from its PTH-like effects. The distinct actions of PLP are at present unknown but may involve effects on cellular proliferation and/or differentiation (13) (14) (15) . It is also likely that, whereas some features of the control of PLP and PTH gene transcription may be shared, others are not. PLP synthesis and/ or secretion has been reported to be regulated by several different agents, including cyclic AMP, phorbol esters, growth factors, and steroid hormones in a number of tumor cell lines (16) (17) (18) (19) and some of these effects appear to be initiated at the transcriptional level (18, 19) . Although originally discovered in a variety of malignancies, mRNA encoding PLP has been identified in both normal and adenomatous tissue of several species. This includes normal human keratinocytes, stomach, normal islet cell, lactating mammary glands, normal and adenomatous parathyroid glands, brain, and fetal liver (20) (21) (22) . In addition, cultured human keratinocytes secrete a material which stimulates adenylate cyclase activity in osteosarcoma cells (23) and may therefore represent a biologically active form of PLP. Primary cultures of keratinocytes proliferate in low calcium concentrations and terminally differentiate when calcium in the medium is raised to or above 1.0 mM (24 (Table I) , albeit in unstimulated cultures collected after 48 h. The higher levels ofimmunoreactive than of bioactive hormone observed may relate to the fact that the standard used for quantitation in both assays was synthetic hPLP . If hPLP (1-34) is not the predominant species released into the culture medium, as seems likely, then it is possible that the native species does not react identically to hPLP(1-34) in both immunoassay and bioassay, i.e., this moiety may react relatively better in the immunoassay resulting in nominally higher immunoreactive concentrations. Nevertheless, in view ofthis correlation, in subsequent studies, to facilitate multiple measurements, only immunoreactive PLP was determined.
Immunocytochemistry. Cellular content of high molecular weight keratin was determined by immunocytochemistry. Cells were seeded in four chamber glass slides (Gibco Laboratories) at a density of 5,000 cells per chamber in KGM and 0.15 mM Ca++ until near confluency. After a 24-h incubation in KBM plus insulin and hydrocortisone, the medium was changed to KGM containing 0.15 or 1.0 mM Ca++ and with or without 1,25(OH)2D3 (10-8 M) for 8 d. Medium was changed after 4 d. Cells were then fixed in 95% ethanol for 5 min, rinsed with distilled water, and stained with a rabbit antibody to high molecular weight keratin (Dakopatts, Dako Corp., Carpinteria, CA) using a modification of the three-layer peroxidase-antiperoxidase technique (36) .
RNA analysis. For Northern blot analysis, GTC extracts were purified by cesium chloride gradient centrifugation (37) and 10 ,g of total RNA was electrophoresed on a 1.1% agarose-formaldehyde gel. Ethidium bromide was added to each sample before electrophoresis to per- mit detection by UV transillumination. RNA was transferred by blotting to a nylon membrane. For dot blot hybridization, samples were processed as described earlier (38 48 and 96 h and assayed for hGH using the Allegro hGH Immunoassay system (Nichols Institute Diagnostics, San Juan Capistrano, CA). Wellto-well variability was assessed in each experiment using pXGH5 (40) which contains the mMT-I promoter and was 21%.
To test for non-PLP promoter-mediated effects of FBS and 1,25(OH)2D3 on hGH synthesis or secretion, keratinocytes were transfected with pONCGH which comprises pOGH with the rat oncomodulin promoter (42) (Fig. 1 ). Further studies with growth factors or serum were performed in the presence of insulin and hydrocortisone which did not alter PLP secretion. Addition of bovine pituitary extract (BPE, 0.4%) or EGF (10 ng/ml) produced small increases in PLP that failed to reach statistical significance. In contrast, addition of EGF plus BPE (GF) produced a twofold augmentation in immunoassayable PLP whereas 10% FBS produced greater than a fourfold increase during the same time period (Fig. 1) .
Effect ofextracellular calcium concentration on PLP secretion. When keratinocytes were incubated with 0.15, 0.5, or 1.0 mM Ca", no significant differences in PLP secretion were observed for up to 96 h. However, cells incubated in 1.0 mM Ca++ calcium demonstrated a marked increase in PLP secretion at 8 d (Fig. 2 ). This effect of 1.0 mM Ca++ was paralleled by an increase in production of high molecular weight keratin by the keratinocytes, indicative ofcellular differentiation (43) (Fig. 3) . No such keratinization was seen with 0.15 mM Ca++ (Fig. 3 ) and only slight keratinization was observed with the intermediate dose (0.5 mM Ca++).
Effect of 1,25(OH)2D3 on PLP secretion. Addition of 1,25(OH)2D3 to the culture medium, in the presence of a low calcium concentration (0. 15 mM) was found to inhibit the stimulatory effect of both GF and FBS at 24 h (Fig. 4) . The time course of this effect of 1,25(OH)2D3 on PLP secretion at low calcium concentration was then examined (Fig. 5) . At 24 and (Fig. 7 A) . A similar early increase in PLP mRNA was also seen after incubation of keratinocytes with 10% FBS. Northern blot analysis revealed the presence of a PLP transcript of 1.4 kb (Fig. 7 B) . Addition of GF to keratinocytes increased expression of this transcript at 1 h, but mRNA levels returned to basal levels by 120 h (Fig. 7 B) . Addition of 1,25(OH)2D3 inhibited this early increase in PLP mRNA (at 1 h). In contrast, 1,25(OH)2D3 increased PLP mRNA at later times ( 120 h), when effects on cellular differentiation were also seen.
Effect ofFBS and 1,25(OH)2D3 on PLPgenepromoter activity. In preliminary experiments, the effects of FBS and of 1,25(OH)2D3 on hGH release by keratinocytes transfected with the construct pONCGH was assessed (Table II) . No stimulation or inhibition of basal activity was observed, thus indicating the absence of nonspecific effects of these agents in the hGH transient transfection assay.
Chimeric constructs containing 0-1.9 kb of the 5' flanking region ofthe rat PLP gene fused to the hGH reporter gene were used to transiently transfect primary cultures of human keratinocytes (Fig. 8) . Stimulation of immunoreactive hGH release by 10% FBS was observed in conditioned medium from cultures of these keratinocytes transfected with constructs containing 1.9 and 1.2 kb ofthe 5' flanking region of the gene (Fig.  9) (20) (21) (22) . Although previous studies have reported regulation of PLP gene expression in tumor cell lines (18, 19) , in this study we have examined regulation of expression and release of the peptide from primary cultures of normal human keratinocytes. GF, such as transforming growth factor-a, are known to be synthesized by keratinocytes which also appear capable of responding to these agents (30, 31 4 . Effect of (t) 1, 25 Although multiple species of PLP mRNA have been reported in extracts of skin, one dominant transcript and occasionally one additional transcript has been reported in primary cultures of keratinocytes (20, 21) . Furthermore, single PLP mRNA transcripts have also been reported in analyses performed with other cultured cells (22, 44) . Whether the appearance of single or dual transcripts in cultured keratinocytes relates to differences in origin ofthe human keratinocytes, differences in preparation or differences in culture conditions is uncertain. Nevertheless, multiple PLP transcripts may not al- Our transient transfection analysis demonstrated that both GF and serum enhanced PLP promoter activity indicating that at least part of the stimulatory effect of these modulators on PLP production in keratinocytes resides at the level of augmenting gene expression. The difference in the apparent kinetics of the effect of growth factors and serum on enhancing endogenous PLP production by keratinocytes and on increasing hGH release during transient transfection assays may re- (11) .
late, at least in part, to the delay involved in handling a foreign protein, i.e., hGH by the keratinocytes. Our studies are consonant with others using the hGH transient transfection system who have shown that GH secretion is only detected after 24 h and is maximally increased at 48-96 h (40).
Our results indicate that PLP gene expression by serum is controlled in keratinocytes by elements lying < 1.2 kb 5' to the cap site. Cis-acting elements responsive to serum, such as the short, conserved, enhancer-like element of c-fos or f3-actin referred to as the serum response element (SRE) are known to regulate the transcription of these eukaryotic genes (49) . We have sequenced 950 bp upstream of the cap site of the rat PLP gene (12) and, in this sequence, we do not find a consensus sequence for an SRE of the c-fos/13-actin type. Therefore, the SRE of the rat PLP gene may lie further upstream, or alternatively, may be unique. Additional studies with deleted portions of the rat PLP gene will be required to more precisely define this SRE.
Our studies also show that the PLP promoter contains a cis-acting element responsive to We have, therefore, demonstrated that PLP is controlled in a well-regulated fashion in normal keratinocytes by both positive and negative modulators. We also demonstrated that the PLP gene promoter contains cis-acting elements capable of responding to these modulators. Identification of these regulatory factors, both extrinsic to the gene and within the PLP gene sequence, can now be used to explore potential sites ofdysregulation associated with the overproduction of PLP. This may provide insights into the mechanism of excess PLP production which can occur during malignant transformation of squamous cells, such as keratinocytes.
